VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
DRIO
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
DRIODarioHealth Corp.
$6.80$337M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksDRIOBalance Sheet

DarioHealth Corp. (DRIO) Balance Sheet

14Y historyFree accessUpdated daily

The company's financial position is increasingly vulnerable, with retained earnings plummeting to -$460.3M and cash reserves declining to $20.3M as of 2026Q1.

DRIO Balance Sheet

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12
Total Current Assets28.47M34.81M40.53M47.33M65.52M45.6M34.13M22.91M13.31M6.05M2.94M4.29M2.06M2.93M1.67M
Cash & Short-Term Investments20.26M26.25M28.46M36.8M49.36M36M28.59M20.59M11M3.98M1.32M2.75M1.54M2.42M1.25M
Cash Only20.26M26.25M27.76M36.8M49.36M36M28.59M20.59M11M3.72M1.09M2.67M1.45M2.26M1.23M
Short-Term Investments00697K000000258K225K80K83K153.6K21.57K
Accounts Receivable2.22M2.67M5.35M3.64M6.42M1.79M1.7M712K234K435K290K22K33K51.48K71.43K
Days Sales Outstanding54.4943.672.2465.3384.6831.7882.134.3811.5530.7137.769.76236.18--
Inventory4.17M4.32M4.75M5.06M7.96M6.23M2.29M1.41M1.38M1.18M888K601K234K00
Days Inventory Outstanding178.04162.51125.96128.59161.32182.68165.31104.0189.29111.9996.35130.7337.56--
Other Current Assets1.81M0175K292K887K0187K0251K258K0291K94K013.42K
Total Non-Current Assets74.81M75.27M78.36M49.06M53.67M55.17M1.28M1.65M776K911K936K790K1.02M1.19M648.91K
Property, Plant & Equipment1.12M01.77M1.87M1.99M989K1.07M1.41M733K869K901K749K978K1.14M617.36K
Fixed Asset Turnover21.66x-15.24x10.91x13.87x20.74x7.05x5.35x10.09x5.95x3.11x1.10x0.05x--
Goodwill57.43M57.43M57.43M41.64M41.64M41.64M000000000
Intangible Assets15.47M15.93M18.76M5.4M9.92M12.46M000000000
Long-Term Investments239K80K06K6K20K017K43K42K35K41K000
Other Non-Current Assets720K1.83M392K143K117K57K205K224K000047K41.17K31.55K
Total Assets103.28M110.08M118.88M96.39M119.19M100.77M35.41M24.57M14.09M6.96M3.87M5.08M3.08M4.12M2.32M
Asset Turnover0.19x0.20x0.23x0.21x0.23x0.20x0.21x0.31x0.52x0.74x0.72x0.16x0.02x--
Asset Growth %-22.3%-7.41%23.34%-19.13%18.28%184.61%44.11%74.38%102.52%79.67%-23.73%64.78%-25.14%77.75%-
Total Current Liabilities9.36M9.32M16.64M12.49M19.35M14.38M7.03M5.22M5.16M3.02M2.92M1.69M1.62M1.51M566.75K
Accounts Payable3.47M2.93M3.04M1.13M2.32M5.11M2.48M1.66M2.57M1.85M1.81M978K708K586K250.35K
Days Payables Outstanding131.25110.2580.728.7347.08149.85178.79121.81166.91175.17196.61212.74113.6415.77-
Short-Term Debt378K430K5.45M3.95M8.82M266K0317K0000000
Deferred Revenue (Current)2.8M714K1.58M997K1.32M1.2M1.22M1.22M736K0031K24K00
Other Current Liabilities5.01M5.25M04.07M2.19M4.4M880K887K880K00434K679K591.4K84.08K
Current Ratio3.04x3.73x2.44x3.79x3.39x3.17x4.85x4.39x2.58x2.01x1.00x2.54x1.27x1.95x2.94x
Quick Ratio2.60x3.27x2.15x3.38x2.98x2.74x4.53x4.12x2.31x1.61x0.70x2.18x1.13x1.95x2.94x
Cash Conversion Cycle101.2895.86117.51165.2198.9264.668.6116.58-66.07-32.47-62.49-72.25160.09--
Total Non-Current Liabilities31.54M32.83M30.23M25.75M19.84M846K222K455K01K7.49M2.61M4M2.7M2.82M
Long-Term Debt30.93M30.75M23.47M24.59M18.11M0000000000
Capital Lease Obligations2.27M571K765K885K827K21K222K455K0000000
Deferred Tax Liabilities000000000000000
Other Non-Current Liabilities106K1.51M5.99M276K910K825K0001K7.49M2.61M4M2.7M2.82M
Total Liabilities40.9M42.15M46.87M38.24M39.19M15.22M7.26M5.67M5.16M3.02M10.41M4.3M5.62M4.2M3.38M
Total Debt31.82M31.75M30.19M29.54M28.05M287K532K772K0002.36M2.76M00
Net Debt11.55M5.5M2.43M-7.26M-21.31M-35.71M-28.06M-19.81M-11M-3.72M-1.09M-314K1.3M-2.26M-1.23M
Debt / Equity0.51x0.47x0.42x0.51x0.35x0.00x0.02x0.04x---3.03x---
Debt / EBITDA-0.59x--------------
Net Debt / EBITDA-0.21x--------------
Interest Coverage-7.68x-10.91x-601.50x-92.04x-22.48x-886.60x-610.27x-655.74x-982.67x-84.32x-541.60x-349.91x---
Total Equity62.38M67.92M72.02M58.14M80M85.55M28.15M18.89M8.93M3.94M-6.54M777K-2.54M-86.38K-1.07M
Equity Growth %1.04%-5.69%23.86%-27.32%-6.49%203.89%48.99%111.7%126.47%160.25%-941.83%130.61%-2838.15%91.92%-
Book Value per Share1.261.371.782.053.385.164.728.347.628.19-25.148.19-105.28-8.49-96.39
Total Shareholders' Equity62.38M67.92M72.02M58.14M80M85.55M28.15M18.89M8.93M3.94M-6.54M777K-2.54M-86.38K-1.07M
Common Stock4K4K4K3K3K2K008K7K6K5K2K2.01K1.45K
Retained Earnings-460.33M-452.08M-390.34M-349.36M-285.85M-222.01M-143.25M-110.14M-89.25M-70.96M-54.96M-43.35M-36.06M-20M-6.07M
Treasury Stock000000000000000
Accumulated OCI00000000-440K-477K-286K-432K-97K-824.9K-24.82K
Minority Interest000000000000000

Key Metrics

Growth RegimeContracting
ProfitabilityNegative
Balance SheetVulnerable
Cash FlowBurning
Top Statement Risk

Insufficient capital runway

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q1)

Diminishing Cash Runway and Liquidity

As reported in recent financial statements, DarioHealth's cash and equivalents have declined to $20.3M in 2026Q1 from a peak of $36.8M in 2023Q4, indicating a tightening liquidity buffer that may necessitate external financing to sustain operations given the company's ongoing negative cash flow profile.

The current ratio of 3.04 suggests adequate short-term coverage, yet this metric is heavily influenced by the composition of current assets which may not be readily convertible to cash. Investors should monitor the burn rate closely, as the rapid depletion of cash reserves relative to operating losses suggests that the company's financial flexibility is narrowing significantly.

Goodwill Concentration Risks Asset Quality

Based on reported figures, goodwill accounts for $57.4M of the company's $103.3M in total assets as of 2026Q1, representing a substantial portion of the balance sheet that warrants further investigation regarding potential impairment risks given the recent 17.31% decline in top-line revenue.

The heavy reliance on intangible assets suggests that the company's book value is sensitive to the performance of past acquisitions. If the B2B pivot fails to generate the anticipated growth, the carrying value of these assets may become increasingly difficult to justify, potentially leading to non-cash charges that would further erode equity.

Equity Erosion Through Accumulated Deficits

According to recent SEC filings, DarioHealth's retained earnings have plummeted to -$460.3M as of 2026Q1, reflecting a persistent pattern of net losses that continues to weigh on the company's total equity base and signals a long-term struggle to achieve operational self-sufficiency.

The consistent accumulation of deficits highlights the structural challenges in the company's business model. While the equity base remains positive, the trend of deepening losses suggests that shareholder value is being systematically depleted, increasing the likelihood of future dilutive equity raises to support the balance sheet.

Leverage Remains Low Despite Losses

As disclosed in quarterly balance sheets, DarioHealth maintains a debt-to-equity ratio of 0.51, which appears relatively conservative; however, this low leverage is likely a function of limited access to traditional credit markets rather than a strategic choice to avoid debt-related interest expenses.

While the debt load of $31.8M is not immediately overwhelming, the company's inability to generate positive operating cash flow makes even modest debt obligations a potential burden. The lack of significant debt suggests that the company has relied primarily on equity financing to fund its operations, which may limit future financing options.

DRIO — Frequently Asked Questions

Quick answers to the most common questions about buying DRIO stock.

What are the total assets of DarioHealth Corp. (DRIO)?

As of 2025, DarioHealth Corp. (DRIO) had total assets of $110.1M including $34.8M in current assets.

How much debt does DarioHealth Corp. (DRIO) have?

DarioHealth Corp. (DRIO) carries total debt of $31.7M, offset by $26.2M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.

What is the book value or shareholders' equity of DarioHealth Corp.?

DarioHealth Corp. (DRIO) has total shareholders' equity (book value) of $67.9M ($1.37 book value per share). Book value represents the net worth of the company belonging to common stock holders.

What is DarioHealth Corp.'s current ratio and liquidity?

DarioHealth Corp. (DRIO) reported a current ratio of 3.73x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.